Home NRBO
1.57
  Price9.79%   +0.14
(After Hours: 1.54 -0.03 -1.91%)
loading

Neurobo Pharmaceuticals (NRBO) Insider Trading

Transactions are not available
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative and cardiometabolic diseases. Its therapeutics programs include NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of protein; and Gemcabene, which is focused on developing and commercializing therapies for the treatment of dyslipidemia. NeuroBo Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Boston, Massachusetts.
Cap:    |  Volume (24h):